Skip to main content
Clinical Trials/NCT00494923
NCT00494923
Unknown
Not Applicable

Glaucoma Including Pseudoexfoliation Syndrome (SFB 539)

University of Erlangen-Nürnberg Medical School1 site in 1 country2,500 target enrollmentJanuary 1999

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Primary Open Angle Glaucoma
Sponsor
University of Erlangen-Nürnberg Medical School
Enrollment
2500
Locations
1
Primary Endpoint
Time to Disease Progression
Last Updated
12 years ago

Overview

Brief Summary

The Erlangen Glaucoma Registry is a clinical registry for cross sectional and longitudinal observation of patients with open angle glaucoma (OAG) or glaucoma suspect, founded in 1991. The primary aim is the evaluation of diagnostic and prognostic validity of morphometrical, sensory and hemodynamical diagnostic procedures. No therapeutic studies are performed.

Detailed Description

Purpose: Detection of onset and progression of structural and functional damage due to glaucoma. Determination of rate and amount of progressive change due to glaucoma. Characterisation of the relationship between structural and functional change over time. Evaluation of predictive factors for the development and progression of glaucoma.

Registry
clinicaltrials.gov
Start Date
January 1999
End Date
December 2020
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University of Erlangen-Nürnberg Medical School
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Open anterior chamber angle
  • Best corrected visual acuity 0.7 or better
  • Age between 18 and 65 years

Exclusion Criteria

  • Any eye disease other than glaucoma
  • Systemic diseases with potentially ocular involvement (e.g., diabetes mellitus)
  • Myopic or hyperopic refractive error exceeding 8.0 diopters

Outcomes

Primary Outcomes

Time to Disease Progression

Time Frame: up to 20 years

Study Sites (1)

Loading locations...

Similar Trials